QCI Interpret for Oncology

Rapid, evidence-based reporting of oncology NGS tests at scale

December 09, 2021
Competing to offer a comprehensive genomic profiling service for solid or hematology oncology tumor samples is challenging, especially as panels increase in size and complexity. QIAGEN Clinical Insight (QCI) Interpret One is clinical decision support software integrated with professional variant interpretation services that enables rapid, evidence-based reporting of oncology NGS tests at scale.

Connected to the world’s most comprehensive, manually curated knowledge base that is updated weekly, QCI Interpret One dynamically computes variant classifications according to AMP/ASCO/CAP and ACMG/AMP guidelines with full transparency. Users get access to over 200,000 pre-formulated, oncologist-reviewed variant interpretation summaries and can build customizable, oncologist-ready reports with the latest diagnostic and prognostic information, as well as biomarker-directed therapies and clinical trials.

In this webinar, attendees will learn:

How QCI Interpret One computes variant classifications
How simple it is to submit variants for professional interpretation via the software
How QCI Interpret One eliminates the need for variant curation
How users can generate customizable, oncologist-ready reports according to AMP/ASCO/CAP guidelines for therapeutic, prognostic, and diagnostic actionability

Beate Litzenburger, PhD
Global Product Director of Oncology
QIAGEN Digital Insights

Sheryl Elkin, PhD
Chief Scientific Officer
N-of-One, a QIAGEN company

Related videos

QCI Interpret for Oncology

Expert insights to advance NGS oncology profiling

286 views February 24, 2021

Recently, GenomeWeb and Qiagen partnered on a survey that allowed...

QCI Interpret for Oncology

QCI Interpret One: Oncology variant interpretation just got more precise

986 views June 12, 2020

Competing to offer a comprehensive genomic profiling service for solid or...

QCI Interpret for Oncology

Reduce your test turnaround for large cancer panels

355 views December 31, 2019

Speaker: Sheryl Elkin, CSO, QDI, QIAGEN Interested in learning more? Click here

QCI Interpret for Oncology

Gaining insights with transcriptomic profiling and mechanistic modeling

340 views June 11, 2021

In this webinar, Moritz Schütte, head of next-generation sequencing data...